Related Experiment Video
Updated: Aug 28, 2025

07:57
Integrated Compensatory Responses in a Human Model of Hemorrhage
Published on: November 20, 2016
12.6K
Blood Utilization and Thresholds for Mortality Following Major Trauma
Andrew B Schneider1, Ursula Adams1, Jared Gallaher1
1Department of Surgery, University of North Carolina, Chapel Hill, North Carolina.
The Journal of Surgical Research
|September 19, 2022
Summary
Massive transfusion protocols aim to manage severe blood loss in trauma. This study found a 50% mortality risk at 31 packed red blood cell units, highlighting the need for judicious blood use in trauma patients.
Area of Science:
- Trauma surgery
- Hemorrhage management
- Blood transfusion medicine
Background:
- Massive transfusion, defined as 10 units of packed red blood cells (PRBCs) in 4 hours, is a critical response to uncontrolled hemorrhage in trauma.
- Blood is a scarce resource, and massive transfusions can deplete hospital supplies with diminishing survival benefits.
Purpose of the Study:
- To identify critical blood transfusion thresholds associated with a predicted mortality exceeding 50% in trauma patients.
- To inform clinical decision-making regarding the judicious use of blood products during massive transfusion events.
Main Methods:
- Analysis of the 2017-2019 National Trauma Database, including 61,676 patients who received at least one unit of PRBCs.
- Utilized bivariate analysis, logistic regression for mortality prediction, and adjusted predicted probability modeling.
Main Results:
- The overall threshold for 50% predicted mortality was 31 units of PRBCs.
- Elderly trauma patients (≥80 years) reached a 50% predicted mortality threshold at 6 units of PRBCs.
Conclusions:
- Surgeons should exercise caution with continued blood administration once the 50% predicted mortality threshold is approached.
- Optimizing blood product utilization is crucial, especially in resource-limited settings and for vulnerable patient populations like the elderly.
Related Concept Videos
Blood Pressure Imbalances and Circulatory Shock
971
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
971
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
288
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
288
Introduction to Hemostasis
8.7K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.7K

